Skip to main content

Table 5 Antimicrobial resistance of Enterococcus and Staphylococcus isolates to the tested antibiotics

From: Shifting trends in bacteriology and antimicrobial resistance among gastrointestinal fistula patients in China: an eight-year review in a tertiary-care hospital

Resistance rate (%)
Isolate/Antibiotics 2008–2011 2012–2015 Total P for Trend Test
Enterococcus
 AMP 72.22 92.45 84.27 0.01
 STH 47.06 57.58 52.24 0.389
 GEH 71.74 79.25 75.76 0.385
 ERY 88.57 88.68 88.64 0.988
 CIP 89.29 90.57 90.12 0.854
 CLI 100.00 95.56 95.92 0.667
 MFX 63.64 91.11 85.71 0.02
 PEN 87.23 92.31 89.90 0.403
 TCY 74.29 69.23 71.26 0.609
 VAN 4.26 9.43 7.00 0.311
 LNZ 4.88 0.00 2.17 0.111
 LVX 77.14 90.38 85.06 0.089
Staphylococcus
 OXA 82.69 93.10 86.42 0.190
 SXT 47.62 24.14 38.03 0.045
 ERY 84.62 82.76 83.95 0.827
 CIP 73.68 89.66 83.33 0.147
 CLI 69.57 57.14 64.86 0.278
 MFX 46.34 37.93 42.86 0.484
 PEN 94.34 100.00 96.34 0.192
 GEN 71.15 72.41 71.60 0.904
 TCY 56.82 68.97 61.64 0.296
 VAN 0.00 0.00 0.00
 LNZ 0.00 0.00 0.00
 LVX 68.89 79.31 72.97 0.324
Not all tested antibiotics are listed
  1. AMP Ampicillin, OXA Oxacillin, STH Streptomycin-High, SXT Trimethoprim/Sulfamethoxazole, ERY erythromycin, GEH gentamicin, CIP ciprofloxacin, CLI Clindamycin, MFX moxifloxacin, PEN penicillin, TCY tetracycline, VAN Vancomycin, LNZ Linezolid, LVX Levofloxacin
  2. Data in boldface reflected p values < 0.05